ReviewAntimicrobial agents and chemotherapy2022

Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections.

Nicole E Scangarella-Oman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.